Polymorphisms of the Interleukin-6 Gene Promoter and Abdominal Aortic Aneurysm

European Journal of Vascular and Endovascular Surgery

Volumn 35, Issue 1, 2008, Pages 31-36

  Smallwood, L ^a   Allcock, R ^a   van Bockxmeer, F ^a   Warrington, N ^b   Palmer, L J ^b   Iacopetta, B ^a   Norman, P E ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Abdominal aortic aneurysm; Interleukin 6; Polymorphism

Indexed keywords

INTERLEUKIN 6;

ABDOMINAL AORTA ANEURYSM; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL; UNIVARIATE ANALYSIS;

AGED; AGED, 80 AND OVER; AORTIC ANEURYSM, ABDOMINAL; CASE-CONTROL STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTERLEUKIN-6; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RISK ASSESSMENT; RISK FACTORS;

EID: 36849070352     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2007.08.021     Document Type: Article

References (30)

1. Lindholt J.S., and Shi G.-P. Chronic inflammation, immune response, and infection in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 31 (2006) 453-563
2. Juvonen J., Surcel H., Satta J., Teppo A.-M., Bloigu A., Syrjala H., et al. Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler Thromb Biol 17 (1997) 2843-2847
3. Engstrom G., Borner G., Lindblad B., Janzon L., and Lindgarde F. Incidence of fatal or repaired abdominal aortic aneurysm in relation to inflammation-sensitive plasma proteins. Arterioscler Thromb Vasc Biol 24 (2004) 337-341
4. Ridker P.M., Nader R., Meir J.S., and Hennekens C.H. Plasma concentration of Interleukin-6 and the risk of future myocardial infarction in apparently healthy men. Circulation 101 (2000) 1767-1772
5. Rohde L.E.P., Arroyo L.H., Rifai N., Creager M.A., Libby P., Ridker P.M., et al. Plasma concentrations of Interleukin-6 and abdominal aortic diameter among subjects without aortic dilatation. Arterioscler Thromb Vasc Biol 19 (1999) 1695-1699
6. Jones K.G., Brull D.J., Brown L.C., Greenhalgh R.M., Humphries S.E., and Powell J.T. Interleukin-6 and the prognosis of abdominal aortic aneurysms. Circulation 103 (2001) 2260-2265
7. Dawson J., Cockerill G., Choke E., Loftus I., and Thompson M.M. Aortic aneurysms as a source of circulating IL-6. Ann NY Acad Sci 1085 (2006) 320-323
8. Senior R.M., Cornelly N.L., and Cury J.D. Elastin degradation by human alveolar macrophages: a prominent role for metalloproteinase activity. Am Rev Respir Dis 139 (1989) 1251-1256
9. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., et al. The effect of novel polymorphisms in the Interleukin-6 gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102 (1998) 1369-1376
10. Terry C.T., Loukaci V., and Green F.R. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 275 (2000) 18138-18144
11. Jamrozik K., Norman P.E., Spencer C.A., Parsons R.W., Tuohy R., Lawrence-Brown M.M., et al. Screening for abdominal aortic aneurysms: lessons from a population-based study. Med J Aust 173 (2000) 345-350
12. Norman P.E., Jamrozik K., Lawrence-Brown M.M., Le M., Spencer C.A., Tuohy R., et al. Population-based randomised controlled trial on impact of screening on mortality from abdominal aortic aneurysm. BMJ 329 (2004) 1259-1262
13. Norman P.E., Spencer C.A., Lawrence-Brown M.M., and Jamrozik K. C-reactive protein levels and the expansion of screen-detected abdominal aortic aneurysms in men. Circulation 110 (2004) 862-866
14. Le M.T.Q., Jamrozik K., TDavis T.M.E., and Norman P.E. Negative association between infra-renal aortic diameter and glycaemia: the health in men study. Eur J Vasc Endovasc Surg 33 (2007) 599-604
15. Norman P.E., Le M.T.Q., Pearce C., and Jamrozik K. Infra-renal aortic diameter predicts all-cause mortality. Arterioscler Thromb Vasc Biol 24 (2004) 1278-1282
16. Grieu F., Joseph D., Norman P., and Iacopetta B. Development of a rapid genotyping method for single nucleotide polymorphisms and its application in cancer studies. Oncol Rep 11 (2004) 501-504
17. Excoffier L., and Slatkin M. Maximum likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 12 (1995) 921-927
18. Dobson J. An Introduction to Generalized Linear Models. 2nd ed (2001), Chapman & Hall/CRC
19. McCaskie P., Carter K.W., and Palmer L.J. SimHap (v2.1 Beta): a comprehensive modelling framework and a simulation based approach to haplotypic analysis of population based data. Available at:. http://www.genepi.org.au/simhap
20. Brull D.J., Montgomery H.E., Sanders J., Dhamrait S., Luong L., Rumley A., et al. Interleukin-6 gene -174G>C and -572G>C promoter polymorphismss are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 21 (2001) 1458-1463
21. Sie M.P.S., Sayed-Tabatabaei F.A., Oei H.H.S., Uitterlinden A.G., Pols H.A.P., Hofman A., et al. Interleukin-6-174G/C promoter polymorphism and risk of coronary heart disaese. Arterioscler Thromb Vasc Biol 26 (2006) 212-217
22. Castell J.V., Gomez-Lechon M.J., David M., Andus T., Geiger T., Tullenque R., et al. Interleukin-6 is a major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett 242 (1989) 237-239
23. Vainas T., Lubbers T., Stassen F.R.M., Herngreen S.B., van Dieijen-Visser M., Bruggeman C.A., et al. Serum C-reactive protein level is associated with abdominal aortic aneurysm size and may be produced by aneurysmal tissue. Circulation 107 (2003) 1103-1105
24. Kluft C., and de Maat M.P.M. Genetics of C-reactive protein. New possibilities and complications. Arterioscler Thromb Vasc Biol 23 (2003) 1956-1959
25. Bennermo M., Held C., Stemme S., Ericsson C.-G., Silviera A., Green F.R., et al. Genetic predisposition of the interleukin-6 response to inflammation: implications for a variety of major diseases?. Clin Chem Lab Med 50 (2004) 2136-2140
26. Bown M.J., Burton P.R., Horsburgh T., Nicholson M.L., Bell P.R.F., and Sayers R.D. The role of cytokine gene polymorphisms in the pathogenesis of abdominal aortic aneurysms: a case control study. J Vasc Surg 37 (2003) 999-1005
27. Shimizu K., Mitchell R.N., and Libby P. Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 26 (2006) 987-994
28. Treska V., Tpolcan O., and Pecan L. Cytokines as plasma markers of abdominal aortic aneurysms. Clin Chem Lab Med 38 (2000) 1161-1164
29. Powell J., Muller B., and Greenhalgh R. Acute phase proteins in patients with abdominal aortic aneurysms. J Cardiovasc Surg 28 (1987) 528-530
30. Marculescu R., Sodeck G., Domanovitis H., Hobusch G., Exner M., Heinzl H., et al. Interleukin-1 gene cluster variants and abdominl aortic aneurysms. Thromb Haemost 94 (2005) 646-650